Table 1.

Percentage of SGLT2i/GLP-1a Use in Veteran DM2 Patients with CVD and/or CKD

	FY 24 Q1	FY 24 Q4
Study Provider 1	50.3	56.8
Study Provider 2	21.1	24.4
Study Provider 3	26.5	32.1
Study Provider 4	47.8	50
Study Provider 5	36.9	41.8
Study Provider 6	40.2	50
Study Provider 7	38.6	37.7
Study Provider 8	40.4	47.6
Avg %	37.725	42.55
% Change Q1-Q4	4.825